aluates Reports

$ 0.0

Automative

Global Glycemic Treatment Drugs Market Research Report 2025

Published Date: May 2025

Report Code: QYRE-Auto-17Q13984

Global Glycemic Treatment Drugs Market Research Report 2023

BUY CHAPTERS

Global Glycemic Treatment Drugs Market Research Report 2025

Code: QYRE-Auto-17Q13984

Report

May 2025

Pages:82

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Sanofi

Merck

Eli Lilly

Boehringer Ingelheim

Novartis

Johnson & Johnson

Astrazeneca plc

Takeda

Bayer

Tonghua Dongbao

Hua Dong

Ganlee

Biocon Ltd.

Novo Nordisk

Glycemic Treatment Drugs Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Glycemic Treatment Drugs Market

The global market for Glycemic Treatment Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Glycemic Treatment Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Glycemic Treatment Drugs.

The Glycemic Treatment Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Glycemic Treatment Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Glycemic Treatment Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Glycemic Treatment Drugs Market Report

Report Metric	Details
Report Name	Glycemic Treatment Drugs Market
CAGR	5%
Segment by Type	Insulin DPP-4 GLP-1 SGLT-2
Segment by Application	Type 1 Diabetes Type 2 Diabetes
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Sanofi, Merck & Co., Novo Nordisk, Eli Lilly, Boehringer Ingelheim, Novartis, Johnson & Johnson, AstraZeneca, Takeda, Bayer, Tonghua DongBao, Hua Dong, Ganlee, Biocon
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Glycemic Treatment Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Glycemic Treatment Drugs Market report?

Ans: The main players in the Glycemic Treatment Drugs Market are Sanofi, Merck & Co., Novo Nordisk, Eli Lilly, Boehringer Ingelheim, Novartis, Johnson & Johnson, AstraZeneca, Takeda, Bayer, Tonghua DongBao, Hua Dong, Ganlee, Biocon

What are the Application segmentation covered in the Glycemic Treatment Drugs Market report?

Ans: The Applications covered in the Glycemic Treatment Drugs Market report are Type 1 Diabetes, Type 2 Diabetes

What are the Type segmentation covered in the Glycemic Treatment Drugs Market report?

Ans: The Types covered in the Glycemic Treatment Drugs Market report are Insulin, DPP-4, GLP-1, SGLT-2

Recommended Reports

Diabetes Management Drugs

Metabolic & Chronic Drugs

Cancer & Specialized Treatments

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Glycemic Treatment Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Insulin

1.2.3 DPP-4

1.2.4 GLP-1

1.2.5 SGLT-2

1.3 Market by Application

1.3.1 Global Glycemic Treatment Drugs Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Type 1 Diabetes

1.3.3 Type 2 Diabetes

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Glycemic Treatment Drugs Market Perspective (2020-2031)

2.2 Global Glycemic Treatment Drugs Growth Trends by Region

2.2.1 Global Glycemic Treatment Drugs Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Glycemic Treatment Drugs Historic Market Size by Region (2020-2025)

2.2.3 Glycemic Treatment Drugs Forecasted Market Size by Region (2026-2031)

2.3 Glycemic Treatment Drugs Market Dynamics

2.3.1 Glycemic Treatment Drugs Industry Trends

2.3.2 Glycemic Treatment Drugs Market Drivers

2.3.3 Glycemic Treatment Drugs Market Challenges

2.3.4 Glycemic Treatment Drugs Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Glycemic Treatment Drugs Players by Revenue

3.1.1 Global Top Glycemic Treatment Drugs Players by Revenue (2020-2025)

3.1.2 Global Glycemic Treatment Drugs Revenue Market Share by Players (2020-2025)

3.2 Global Glycemic Treatment Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Glycemic Treatment Drugs Revenue

3.4 Global Glycemic Treatment Drugs Market Concentration Ratio

3.4.1 Global Glycemic Treatment Drugs Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Glycemic Treatment Drugs Revenue in 2024

3.5 Global Key Players of Glycemic Treatment Drugs Head office and Area Served

3.6 Global Key Players of Glycemic Treatment Drugs, Product and Application

3.7 Global Key Players of Glycemic Treatment Drugs, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Glycemic Treatment Drugs Breakdown Data by Type

4.1 Global Glycemic Treatment Drugs Historic Market Size by Type (2020-2025)

4.2 Global Glycemic Treatment Drugs Forecasted Market Size by Type (2026-2031)

5 Glycemic Treatment Drugs Breakdown Data by Application

5.1 Global Glycemic Treatment Drugs Historic Market Size by Application (2020-2025)

5.2 Global Glycemic Treatment Drugs Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Glycemic Treatment Drugs Market Size (2020-2031)

6.2 North America Glycemic Treatment Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Glycemic Treatment Drugs Market Size by Country (2020-2025)

6.4 North America Glycemic Treatment Drugs Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Glycemic Treatment Drugs Market Size (2020-2031)

7.2 Europe Glycemic Treatment Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Glycemic Treatment Drugs Market Size by Country (2020-2025)

7.4 Europe Glycemic Treatment Drugs Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Glycemic Treatment Drugs Market Size (2020-2031)

8.2 Asia-Pacific Glycemic Treatment Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Glycemic Treatment Drugs Market Size by Region (2020-2025)

8.4 Asia-Pacific Glycemic Treatment Drugs Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Glycemic Treatment Drugs Market Size (2020-2031)

9.2 Latin America Glycemic Treatment Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Glycemic Treatment Drugs Market Size by Country (2020-2025)

9.4 Latin America Glycemic Treatment Drugs Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Glycemic Treatment Drugs Market Size (2020-2031)

10.2 Middle East & Africa Glycemic Treatment Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Glycemic Treatment Drugs Market Size by Country (2020-2025)

10.4 Middle East & Africa Glycemic Treatment Drugs Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Sanofi

11.1.1 Sanofi Company Details

11.1.2 Sanofi Business Overview

11.1.3 Sanofi Glycemic Treatment Drugs Introduction

11.1.4 Sanofi Revenue in Glycemic Treatment Drugs Business (2020-2025)

11.1.5 Sanofi Recent Development

11.2 Merck & Co.

11.2.1 Merck & Co. Company Details

11.2.2 Merck & Co. Business Overview

11.2.3 Merck & Co. Glycemic Treatment Drugs Introduction

11.2.4 Merck & Co. Revenue in Glycemic Treatment Drugs Business (2020-2025)

11.2.5 Merck & Co. Recent Development

11.3 Novo Nordisk

11.3.1 Novo Nordisk Company Details

11.3.2 Novo Nordisk Business Overview

11.3.3 Novo Nordisk Glycemic Treatment Drugs Introduction

11.3.4 Novo Nordisk Revenue in Glycemic Treatment Drugs Business (2020-2025)

11.3.5 Novo Nordisk Recent Development

11.4 Eli Lilly

11.4.1 Eli Lilly Company Details

11.4.2 Eli Lilly Business Overview

11.4.3 Eli Lilly Glycemic Treatment Drugs Introduction

11.4.4 Eli Lilly Revenue in Glycemic Treatment Drugs Business (2020-2025)

11.4.5 Eli Lilly Recent Development

11.5 Boehringer Ingelheim

11.5.1 Boehringer Ingelheim Company Details

11.5.2 Boehringer Ingelheim Business Overview

11.5.3 Boehringer Ingelheim Glycemic Treatment Drugs Introduction

11.5.4 Boehringer Ingelheim Revenue in Glycemic Treatment Drugs Business (2020-2025)

11.5.5 Boehringer Ingelheim Recent Development

11.6 Novartis

11.6.1 Novartis Company Details

11.6.2 Novartis Business Overview

11.6.3 Novartis Glycemic Treatment Drugs Introduction

11.6.4 Novartis Revenue in Glycemic Treatment Drugs Business (2020-2025)

11.6.5 Novartis Recent Development

11.7 Johnson & Johnson

11.7.1 Johnson & Johnson Company Details

11.7.2 Johnson & Johnson Business Overview

11.7.3 Johnson & Johnson Glycemic Treatment Drugs Introduction

11.7.4 Johnson & Johnson Revenue in Glycemic Treatment Drugs Business (2020-2025)

11.7.5 Johnson & Johnson Recent Development

11.8 AstraZeneca

11.8.1 AstraZeneca Company Details

11.8.2 AstraZeneca Business Overview

11.8.3 AstraZeneca Glycemic Treatment Drugs Introduction

11.8.4 AstraZeneca Revenue in Glycemic Treatment Drugs Business (2020-2025)

11.8.5 AstraZeneca Recent Development

11.9 Takeda

11.9.1 Takeda Company Details

11.9.2 Takeda Business Overview

11.9.3 Takeda Glycemic Treatment Drugs Introduction

11.9.4 Takeda Revenue in Glycemic Treatment Drugs Business (2020-2025)

11.9.5 Takeda Recent Development

11.10 Bayer

11.10.1 Bayer Company Details

11.10.2 Bayer Business Overview

11.10.3 Bayer Glycemic Treatment Drugs Introduction

11.10.4 Bayer Revenue in Glycemic Treatment Drugs Business (2020-2025)

11.10.5 Bayer Recent Development

11.11 Tonghua DongBao

11.11.1 Tonghua DongBao Company Details

11.11.2 Tonghua DongBao Business Overview

11.11.3 Tonghua DongBao Glycemic Treatment Drugs Introduction

11.11.4 Tonghua DongBao Revenue in Glycemic Treatment Drugs Business (2020-2025)

11.11.5 Tonghua DongBao Recent Development

11.12 Hua Dong

11.12.1 Hua Dong Company Details

11.12.2 Hua Dong Business Overview

11.12.3 Hua Dong Glycemic Treatment Drugs Introduction

11.12.4 Hua Dong Revenue in Glycemic Treatment Drugs Business (2020-2025)

11.12.5 Hua Dong Recent Development

11.13 Ganlee

11.13.1 Ganlee Company Details

11.13.2 Ganlee Business Overview

11.13.3 Ganlee Glycemic Treatment Drugs Introduction

11.13.4 Ganlee Revenue in Glycemic Treatment Drugs Business (2020-2025)

11.13.5 Ganlee Recent Development

11.14 Biocon

11.14.1 Biocon Company Details

11.14.2 Biocon Business Overview

11.14.3 Biocon Glycemic Treatment Drugs Introduction

11.14.4 Biocon Revenue in Glycemic Treatment Drugs Business (2020-2025)

11.14.5 Biocon Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Sanofi

Merck

Eli Lilly

Boehringer Ingelheim

Novartis

Johnson & Johnson

Astrazeneca plc

Takeda

Bayer

Tonghua Dongbao

Hua Dong

Ganlee

Biocon Ltd.

Novo Nordisk

List of Tables

Table 1. Global Glycemic Treatment Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Insulin

Table 3. Key Players of DPP-4

Table 4. Key Players of GLP-1

Table 5. Key Players of SGLT-2

Table 6. Global Glycemic Treatment Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Glycemic Treatment Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Glycemic Treatment Drugs Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global Glycemic Treatment Drugs Market Share by Region (2020-2025)

Table 10. Global Glycemic Treatment Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global Glycemic Treatment Drugs Market Share by Region (2026-2031)

Table 12. Glycemic Treatment Drugs Market Trends

Table 13. Glycemic Treatment Drugs Market Drivers

Table 14. Glycemic Treatment Drugs Market Challenges

Table 15. Glycemic Treatment Drugs Market Restraints

Table 16. Global Glycemic Treatment Drugs Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global Glycemic Treatment Drugs Market Share by Players (2020-2025)

Table 18. Global Top Glycemic Treatment Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Glycemic Treatment Drugs as of 2024)

Table 19. Ranking of Global Top Glycemic Treatment Drugs Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by Glycemic Treatment Drugs Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of Glycemic Treatment Drugs, Headquarters and Area Served

Table 22. Global Key Players of Glycemic Treatment Drugs, Product and Application

Table 23. Global Key Players of Glycemic Treatment Drugs, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Glycemic Treatment Drugs Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global Glycemic Treatment Drugs Revenue Market Share by Type (2020-2025)

Table 27. Global Glycemic Treatment Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global Glycemic Treatment Drugs Revenue Market Share by Type (2026-2031)

Table 29. Global Glycemic Treatment Drugs Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global Glycemic Treatment Drugs Revenue Market Share by Application (2020-2025)

Table 31. Global Glycemic Treatment Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global Glycemic Treatment Drugs Revenue Market Share by Application (2026-2031)

Table 33. North America Glycemic Treatment Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America Glycemic Treatment Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America Glycemic Treatment Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe Glycemic Treatment Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe Glycemic Treatment Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe Glycemic Treatment Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific Glycemic Treatment Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific Glycemic Treatment Drugs Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific Glycemic Treatment Drugs Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America Glycemic Treatment Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America Glycemic Treatment Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America Glycemic Treatment Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa Glycemic Treatment Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa Glycemic Treatment Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa Glycemic Treatment Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 48. Sanofi Company Details

Table 49. Sanofi Business Overview

Table 50. Sanofi Glycemic Treatment Drugs Product

Table 51. Sanofi Revenue in Glycemic Treatment Drugs Business (2020-2025) & (US$ Million)

Table 52. Sanofi Recent Development

Table 53. Merck & Co. Company Details

Table 54. Merck & Co. Business Overview

Table 55. Merck & Co. Glycemic Treatment Drugs Product

Table 56. Merck & Co. Revenue in Glycemic Treatment Drugs Business (2020-2025) & (US$ Million)

Table 57. Merck & Co. Recent Development

Table 58. Novo Nordisk Company Details

Table 59. Novo Nordisk Business Overview

Table 60. Novo Nordisk Glycemic Treatment Drugs Product

Table 61. Novo Nordisk Revenue in Glycemic Treatment Drugs Business (2020-2025) & (US$ Million)

Table 62. Novo Nordisk Recent Development

Table 63. Eli Lilly Company Details

Table 64. Eli Lilly Business Overview

Table 65. Eli Lilly Glycemic Treatment Drugs Product

Table 66. Eli Lilly Revenue in Glycemic Treatment Drugs Business (2020-2025) & (US$ Million)

Table 67. Eli Lilly Recent Development

Table 68. Boehringer Ingelheim Company Details

Table 69. Boehringer Ingelheim Business Overview

Table 70. Boehringer Ingelheim Glycemic Treatment Drugs Product

Table 71. Boehringer Ingelheim Revenue in Glycemic Treatment Drugs Business (2020-2025) & (US$ Million)

Table 72. Boehringer Ingelheim Recent Development

Table 73. Novartis Company Details

Table 74. Novartis Business Overview

Table 75. Novartis Glycemic Treatment Drugs Product

Table 76. Novartis Revenue in Glycemic Treatment Drugs Business (2020-2025) & (US$ Million)

Table 77. Novartis Recent Development

Table 78. Johnson & Johnson Company Details

Table 79. Johnson & Johnson Business Overview

Table 80. Johnson & Johnson Glycemic Treatment Drugs Product

Table 81. Johnson & Johnson Revenue in Glycemic Treatment Drugs Business (2020-2025) & (US$ Million)

Table 82. Johnson & Johnson Recent Development

Table 83. AstraZeneca Company Details

Table 84. AstraZeneca Business Overview

Table 85. AstraZeneca Glycemic Treatment Drugs Product

Table 86. AstraZeneca Revenue in Glycemic Treatment Drugs Business (2020-2025) & (US$ Million)

Table 87. AstraZeneca Recent Development

Table 88. Takeda Company Details

Table 89. Takeda Business Overview

Table 90. Takeda Glycemic Treatment Drugs Product

Table 91. Takeda Revenue in Glycemic Treatment Drugs Business (2020-2025) & (US$ Million)

Table 92. Takeda Recent Development

Table 93. Bayer Company Details

Table 94. Bayer Business Overview

Table 95. Bayer Glycemic Treatment Drugs Product

Table 96. Bayer Revenue in Glycemic Treatment Drugs Business (2020-2025) & (US$ Million)

Table 97. Bayer Recent Development

Table 98. Tonghua DongBao Company Details

Table 99. Tonghua DongBao Business Overview

Table 100. Tonghua DongBao Glycemic Treatment Drugs Product

Table 101. Tonghua DongBao Revenue in Glycemic Treatment Drugs Business (2020-2025) & (US$ Million)

Table 102. Tonghua DongBao Recent Development

Table 103. Hua Dong Company Details

Table 104. Hua Dong Business Overview

Table 105. Hua Dong Glycemic Treatment Drugs Product

Table 106. Hua Dong Revenue in Glycemic Treatment Drugs Business (2020-2025) & (US$ Million)

Table 107. Hua Dong Recent Development

Table 108. Ganlee Company Details

Table 109. Ganlee Business Overview

Table 110. Ganlee Glycemic Treatment Drugs Product

Table 111. Ganlee Revenue in Glycemic Treatment Drugs Business (2020-2025) & (US$ Million)

Table 112. Ganlee Recent Development

Table 113. Biocon Company Details

Table 114. Biocon Business Overview

Table 115. Biocon Glycemic Treatment Drugs Product

Table 116. Biocon Revenue in Glycemic Treatment Drugs Business (2020-2025) & (US$ Million)

Table 117. Biocon Recent Development

Table 118. Research Programs/Design for This Report

Table 119. Key Data Information from Secondary Sources

Table 120. Key Data Information from Primary Sources

Table 121. Authors List of This Report

List of Figures

Figure 1. Glycemic Treatment Drugs Picture

Figure 2. Global Glycemic Treatment Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Glycemic Treatment Drugs Market Share by Type: 2024 VS 2031

Figure 4. Insulin Features

Figure 5. DPP-4 Features

Figure 6. GLP-1 Features

Figure 7. SGLT-2 Features

Figure 8. Global Glycemic Treatment Drugs Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global Glycemic Treatment Drugs Market Share by Application: 2024 VS 2031

Figure 10. Type 1 Diabetes Case Studies

Figure 11. Type 2 Diabetes Case Studies

Figure 12. Glycemic Treatment Drugs Report Years Considered

Figure 13. Global Glycemic Treatment Drugs Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global Glycemic Treatment Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Glycemic Treatment Drugs Market Share by Region: 2024 VS 2031

Figure 16. Global Glycemic Treatment Drugs Market Share by Players in 2024

Figure 17. Global Top Glycemic Treatment Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Glycemic Treatment Drugs as of 2024)

Figure 18. The Top 10 and 5 Players Market Share by Glycemic Treatment Drugs Revenue in 2024

Figure 19. North America Glycemic Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America Glycemic Treatment Drugs Market Share by Country (2020-2031)

Figure 21. United States Glycemic Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada Glycemic Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Glycemic Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Glycemic Treatment Drugs Market Share by Country (2020-2031)

Figure 25. Germany Glycemic Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France Glycemic Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. Glycemic Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy Glycemic Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia Glycemic Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries Glycemic Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Glycemic Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Glycemic Treatment Drugs Market Share by Region (2020-2031)

Figure 33. China Glycemic Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan Glycemic Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea Glycemic Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia Glycemic Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India Glycemic Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia Glycemic Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Glycemic Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Glycemic Treatment Drugs Market Share by Country (2020-2031)

Figure 41. Mexico Glycemic Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil Glycemic Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Glycemic Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Glycemic Treatment Drugs Market Share by Country (2020-2031)

Figure 45. Turkey Glycemic Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia Glycemic Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE Glycemic Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Sanofi Revenue Growth Rate in Glycemic Treatment Drugs Business (2020-2025)

Figure 49. Merck & Co. Revenue Growth Rate in Glycemic Treatment Drugs Business (2020-2025)

Figure 50. Novo Nordisk Revenue Growth Rate in Glycemic Treatment Drugs Business (2020-2025)

Figure 51. Eli Lilly Revenue Growth Rate in Glycemic Treatment Drugs Business (2020-2025)

Figure 52. Boehringer Ingelheim Revenue Growth Rate in Glycemic Treatment Drugs Business (2020-2025)

Figure 53. Novartis Revenue Growth Rate in Glycemic Treatment Drugs Business (2020-2025)

Figure 54. Johnson & Johnson Revenue Growth Rate in Glycemic Treatment Drugs Business (2020-2025)

Figure 55. AstraZeneca Revenue Growth Rate in Glycemic Treatment Drugs Business (2020-2025)

Figure 56. Takeda Revenue Growth Rate in Glycemic Treatment Drugs Business (2020-2025)

Figure 57. Bayer Revenue Growth Rate in Glycemic Treatment Drugs Business (2020-2025)

Figure 58. Tonghua DongBao Revenue Growth Rate in Glycemic Treatment Drugs Business (2020-2025)

Figure 59. Hua Dong Revenue Growth Rate in Glycemic Treatment Drugs Business (2020-2025)

Figure 60. Ganlee Revenue Growth Rate in Glycemic Treatment Drugs Business (2020-2025)

Figure 61. Biocon Revenue Growth Rate in Glycemic Treatment Drugs Business (2020-2025)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Diabetes Therapy Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Antidiabetic Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Severe Hypoglycemia Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Oral Hypoglycemic Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Non Insulin Therapies for Diabetes Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Type 2 Diabetes Therapeutics Market Research Report 2025

Global Non Insulin Hypoglycemic Drug Market Research Report 2025

Global Diabetic Therapeutic Drugs Market Research Report 2025

Global Combination Anti Diabetes Drugs Market Research Report 2025

Antidiabetic Combination Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Diabetic Retinopathy Fundus Image assisted Diagnosis Software Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Sickle Cell Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Chronic Metabolic Disease Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Diabetes Stem Cell Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Incretin Based Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Prescription Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Drug Delivery Technologies Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Systemic Infection Treatment Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Treatment Planning Software Market Research Report 2025

RELATED REPORTS

Global Taurine and Derivatives Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-26D19461

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global OTC Hydrotalcite Chewable Tablets Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-18S16538

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Women's Fat Burners Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-14W1499

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Beef Protein Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-39Y12110

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions